AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus

In a double data drop Thursday, AbbVie touted two clinical trial wins, for Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus.